Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Pollack

Showing results (31-40 of 265) with videos related to

Pageof 27
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 21, 2007
Is proton beam therapy cost effective in the treatment of adenocarcinoma of the prostate?Andre Konski, William Speier, Alexandra Hanlon, et al.
JAMA|March 8, 2007
Advanced prostate cancer and postoperative radiotherapyThomas M Pisansky, Alan Pollack, Howard M Sandler, et al.
Molecular Cancer Research : MCR|November 18, 2008
Antisense MDM2 enhances E2F1-induced apoptosis and the combination sensitizes androgen-sensitive [corrected] and androgen-insensitive [corrected] prostate cancer cells to radiationThirupandiyur S Udayakumar, Paul Hachem, Mansoor M Ahmed, et al.
International Journal of Radiation Oncology, Biology, Physics|January 4, 2011
Adenovirus E2F1 overexpression sensitizes LNCaP and PC3 prostate tumor cells to radiation in vivoThirupandiyur S Udayakumar, Radka Stoyanova, Paul Hachem, et al.
Cancer|November 30, 2006
Prostate-specific antigen nadir within 12 months of prostate cancer radiotherapy predicts metastasis and deathPino Alcantara, Alexandra Hanlon, Mark K Buyyounouski, et al.
Journal of the American College of Radiology : JACR|December 30, 2008
Developing a radiation error scoring system to monitor quality control events in a radiation oncology departmentAndre Konski, Benjamin Movsas, Maryann Konopka, et al.
Cancer|May 10, 2006
Does age matter in the selection of treatment for men with early-stage prostate cancer?Andre Konski, Debra Eisenberg, Eric Horwitz, et al.
Journal of Applied Clinical Medical Physics|October 20, 2018
Assessment of specific versus combined purpose knowledge based models in prostate radiotherapyElizabeth Bossart, Melissa Duffy, Garrett Simpson, et al.
Lancet (London, England)|September 18, 2022
The addition of pelvic lymph node treatment to prostate bed salvage radiotherapy - Authors' replyAlan Pollack, Theodore G Karrison, Felix Feng, et al.
Medical Physics|June 20, 2017
Optical molecular imaging-guided radiation therapy part 2: Integrated x-ray and fluorescence molecular tomographyJunwei Shi, Thirupandiyur S Udayakumar, Zhiqun Wang, et al.
Pageof 27

Showing results (31-40 of 265) with videos related to

Sort By:
Pageof 27
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 21, 2007
Is proton beam therapy cost effective in the treatment of adenocarcinoma of the prostate?Andre Konski, William Speier, Alexandra Hanlon, et al.
JAMA|March 8, 2007
Advanced prostate cancer and postoperative radiotherapyThomas M Pisansky, Alan Pollack, Howard M Sandler, et al.
Molecular Cancer Research : MCR|November 18, 2008
Antisense MDM2 enhances E2F1-induced apoptosis and the combination sensitizes androgen-sensitive [corrected] and androgen-insensitive [corrected] prostate cancer cells to radiationThirupandiyur S Udayakumar, Paul Hachem, Mansoor M Ahmed, et al.
International Journal of Radiation Oncology, Biology, Physics|January 4, 2011
Adenovirus E2F1 overexpression sensitizes LNCaP and PC3 prostate tumor cells to radiation in vivoThirupandiyur S Udayakumar, Radka Stoyanova, Paul Hachem, et al.
Cancer|November 30, 2006
Prostate-specific antigen nadir within 12 months of prostate cancer radiotherapy predicts metastasis and deathPino Alcantara, Alexandra Hanlon, Mark K Buyyounouski, et al.
Journal of the American College of Radiology : JACR|December 30, 2008
Developing a radiation error scoring system to monitor quality control events in a radiation oncology departmentAndre Konski, Benjamin Movsas, Maryann Konopka, et al.
Cancer|May 10, 2006
Does age matter in the selection of treatment for men with early-stage prostate cancer?Andre Konski, Debra Eisenberg, Eric Horwitz, et al.
Journal of Applied Clinical Medical Physics|October 20, 2018
Assessment of specific versus combined purpose knowledge based models in prostate radiotherapyElizabeth Bossart, Melissa Duffy, Garrett Simpson, et al.
Lancet (London, England)|September 18, 2022
The addition of pelvic lymph node treatment to prostate bed salvage radiotherapy - Authors' replyAlan Pollack, Theodore G Karrison, Felix Feng, et al.
Medical Physics|June 20, 2017
Optical molecular imaging-guided radiation therapy part 2: Integrated x-ray and fluorescence molecular tomographyJunwei Shi, Thirupandiyur S Udayakumar, Zhiqun Wang, et al.
Pageof 27